» Authors » Sakiko Inamoto

Sakiko Inamoto

Explore the profile of Sakiko Inamoto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 497
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Inamoto S, Kwartler C, Lafont A, Liang Y, Fadulu V, Duraisamy S, et al.
Cardiovasc Res . 2010 Jul; 88(3):520-9. PMID: 20628007
Aims: Transforming growth factor-β (TGF-β) signaling is critical for the differentiation of smooth muscle cells (SMCs) into quiescent cells expressing a full repertoire of contractile proteins. Heterozygous mutations in TGF-β...
2.
Inamoto S, Yoshioka T, Yamashita C, Miyamura M, Mori T, Ukimura A, et al.
Hypertens Res . 2010 Mar; 33(6):579-86. PMID: 20300107
We have reported previously that intermittent hypoxia related to sleep apnea induces cardiovascular remodeling secondary to the oxidative stress. The aim of this study was to examine the effect of...
3.
Milewicz D, Guo D, Tran-Fadulu V, Lafont A, Papke C, Inamoto S, et al.
Annu Rev Genomics Hum Genet . 2008 Jun; 9:283-302. PMID: 18544034
Thoracic aortic aneurysms leading to type A dissections (TAAD) can be inherited in isolation or in association with genetic syndromes, such as Marfan syndrome and Loeys-Dietz syndrome. When TAAD occurs...
4.
Inamoto T, Yamada T, Ohnuma K, Kina S, Takahashi N, Yamochi T, et al.
Clin Cancer Res . 2007 Jul; 13(14):4191-200. PMID: 17634548
Purpose: CD26 is a 110-kDa cell surface antigen with a role in tumor development. In this report, we show that CD26 is highly expressed on the cell surface of malignant...
5.
Inamoto T, Yamochi T, Ohnuma K, Iwata S, Kina S, Inamoto S, et al.
Clin Cancer Res . 2006 Jun; 12(11 Pt 1):3470-7. PMID: 16740772
Purpose: CD26 is a 110-kDa cell surface glycoprotein with a role in tumor development through its association with key intracellular proteins. In this report, we show that binding of soluble...
6.
Inamoto S, Hayashi T, Tazawa N, Mori T, Yamashita C, Nakano D, et al.
Circ J . 2006 May; 70(6):787-92. PMID: 16723804
Background: Hypoxia caused by sleep apnea might be associated with an increased risk of cardiovascular events in subjects with metabolic syndrome. The aim of this study was to examine the...
7.
Nakano D, Hayashi T, Tazawa N, Yamashita C, Inamoto S, Okuda N, et al.
Hypertens Res . 2006 Feb; 28(10):837-45. PMID: 16471178
The aim of this study was to investigate the effect of chronic hypoxia on the development and progression of atherosclerosis in apolipoprotein E-knockout (apoE-KO) mice. Male and female apoE-KO mice...
8.
Okuda N, Hayashi T, Mori T, Inamoto S, Okabe M, Mieno S, et al.
Hypertens Res . 2005 Sep; 28(5):431-8. PMID: 16156507
This study was designed to examine the hypothesis that a calcium channel blocker nifedipine (CCB) could enhance the cardioprotective effect of an angiotensin-ll receptor blocker candesartan (ARB) in the treatment...
9.
Matsumoto R, Omura T, Yoshiyama M, Hayashi T, Inamoto S, Koh K, et al.
Arterioscler Thromb Vasc Biol . 2005 Apr; 25(6):1168-73. PMID: 15831811
Objective: Vascular endothelial growth factor (VEGF) plays an important role in inducing angiogenesis. Mesenchymal stem cells (MSCs) may have potential for differentiation to several types of cells, including myocytes. We...
10.
Omura T, Yoshiyama M, Hayashi T, Nishiguchi S, Kaito M, Horiike S, et al.
Circ Res . 2004 Dec; 96(2):148-50. PMID: 15618537
Hepatitis C virus (HCV) has been reported to be associated with cardiomyopathy. However, the mechanism of cardiomyopathy in chronic HCV infection is still unclear. Therefore, we investigate the development of...